ASF1B and glioblastoma: However, among the individuals with CESC (Figure 2K, p < 0.001), GBM (Figure 2L, p = 0.033), LUSC (Figure 2M, p = 0.021), SKCM (Figure 2N, p < 0.001), STAD (Figure 2O, p = 0.039), and THYM (Figure 2P, p = 0.018), those with high ASF1B expression had increased survival.